Eigen Bio to Present at TechCrunch Disrupt 2026

Eigen Bio has been selected to present at TechCrunch Disrupt 2026, where the team will showcase ORIGIN™'s capabilities in early cancer detection and drug target identification.

The presentation will feature new benchmarking results demonstrating ORIGIN™'s performance across multiple cancer types, including data from ongoing collaborations with leading research institutions.

"We're excited to share our progress with the broader tech and biotech community," said Ryan Kim, Co-Founder and CSO. "The results we're seeing validate our approach to RNA foundation models."

TechCrunch Disrupt 2026 takes place September 15-17 in San Francisco.